Brandt MR - Search Results

1

Prodrugs of perzinfotel with improved oral bioavailability.

Baudy RB, Butera JA, Abou-Gharbia MA, Chen H, Harrison B, Jain U, Magolda R, Sze JY, Brandt MR, Cummons TA, Kowal D, Pangalos MN, Zupan B, Hoffmann M, May M, Mugford C, Kennedy J, Childers WE Jr. Baudy RB, et al. Among authors: brandt mr. J Med Chem. 2009 Feb 12;52(3):771-8. doi: 10.1021/jm8011799. J Med Chem. 2009. PMID: 19146418

2

Effects of the N-methyl-D-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity.

Brandt MR, Cummons TA, Potestio L, Sukoff SJ, Rosenzweig-Lipson S. Brandt MR, et al. J Pharmacol Exp Ther. 2005 Jun;313(3):1379-86. doi: 10.1124/jpet.105.084467. Epub 2005 Mar 11. J Pharmacol Exp Ther. 2005. PMID: 15764736

3

An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.

Leventhal L, Brandt MR, Cummons TA, Piesla MJ, Rogers KE, Harris HA. Leventhal L, et al. Among authors: brandt mr. Eur J Pharmacol. 2006 Dec 28;553(1-3):146-8. doi: 10.1016/j.ejphar.2006.09.033. Epub 2006 Sep 26. Eur J Pharmacol. 2006. PMID: 17056036

4

Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain.

Leventhal L, Smith V, Hornby G, Andree TH, Brandt MR, Rogers KE. Leventhal L, et al. Among authors: brandt mr. J Pharmacol Exp Ther. 2007 Mar;320(3):1178-85. doi: 10.1124/jpet.106.109728. Epub 2006 Dec 1. J Pharmacol Exp Ther. 2007. PMID: 17142646

5

Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli.

Smith VA, Beyer CE, Brandt MR. Smith VA, et al. Among authors: brandt mr. Brain Res. 2006 Jun 20;1095(1):65-72. doi: 10.1016/j.brainres.2006.04.018. Epub 2006 May 30. Brain Res. 2006. PMID: 16730668

6

Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.

Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR, Dawson LA, Cole D, Bernotas R, Robichaud A, Rosenzweig-Lipson S, Beyer CE. Schechter LE, et al. Among authors: brandt mr. Neuropsychopharmacology. 2008 May;33(6):1323-35. doi: 10.1038/sj.npp.1301503. Epub 2007 Jul 11. Neuropsychopharmacology. 2008. PMID: 17625499

7

Quality Assurance Investigations and Impurity Characterization during Upscaling of [¹⁷⁷Lu]Lu-PSMA^I&T.

Schmitl S, Raitanen J, Witoszynskyj S, Patronas EM, Nics L, Ozenil M, Weissenböck V, Mindt TL, Hacker M, Wadsak W, Brandt MR, Mitterhauser M. Schmitl S, et al. Among authors: brandt mr. Molecules. 2023 Nov 21;28(23):7696. doi: 10.3390/molecules28237696. Molecules. 2023. PMID: 38067427 Free PMC article.

8

Unexpected transformation of n.c.a. [¹¹¹In]InCl₃ in stock solutions into an unreactive [¹¹¹In]In-species.

Giammei C, Jouini N, Brandt MR, Frey S, Mindt TL, Cardinale J. Giammei C, et al. Among authors: brandt mr. Appl Radiat Isot. 2022 Feb;180:110037. doi: 10.1016/j.apradiso.2021.110037. Epub 2021 Dec 1. Appl Radiat Isot. 2022. PMID: 34864558

9

The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.

Zhu B, Connolly PJ, Zhang YM, McDonnell ME, Bian H, Lin SC, Liu L, Zhang SP, Chevalier KM, Brandt MR, Milligan CM, Flores CM, Macielag MJ. Zhu B, et al. Among authors: brandt mr. Bioorg Med Chem Lett. 2020 Jul 15;30(14):127243. doi: 10.1016/j.bmcl.2020.127243. Epub 2020 May 7. Bioorg Med Chem Lett. 2020. PMID: 32527545

10

Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.

Wyatt RM, Fraser I, Welty N, Lord B, Wennerholm M, Sutton S, Ameriks MK, Dugovic C, Yun S, White A, Nguyen L, Koudriakova T, Tian G, Suarez J, Szewczuk L, Bonnette W, Ahn K, Ghosh B, Flores CM, Connolly PJ, Zhu B, Macielag MJ, Brandt MR, Chevalier K, Zhang SP, Lovenberg T, Bonaventure P. Wyatt RM, et al. Among authors: brandt mr. J Pharmacol Exp Ther. 2020 Mar;372(3):339-353. doi: 10.1124/jpet.119.262139. Epub 2019 Dec 9. J Pharmacol Exp Ther. 2020. PMID: 31818916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page